Exciting news on the psychedelic medicine front

Schalk Neethling
3 min readDec 20, 2021

--

Photo by Beth Macdonald on Unsplash

I have been following the research on the use of plant medicine such as psychedelics in the treatment of PSD, treatment resistant depression, addiction, and anxiety.

“Let food be thy medicine”- Hippocrates

I have been following a whole food plant based diet for a very long time. I do credit it with saving me from many of the physical adverse affects of my addiction. I have also believed that their are many plant medicines which are illegal for no good reason other then political propaganda and long held believes not based on science.

I have been following the work of many people but, especially the work of Michael Pollan. In the most recent post of his Substack newsletter, The Microdose, he shared some exciting news as quoted below:

Cybin scores a tryptamine patent. Psychedelic pharmaceutical company Cybin announced that the US Patent Office has sent them a notice of allowance (essentially, a heads up that the USPO intends to grant a patent) for CYB004, a “deuterated psychedelic tryptamine” to treat anxiety disorders.

First thing to know: a tryptamine is a class of compounds that includes psilocybin, DMT and 5-MeO-DMT. This patent covers what Cybin claims is a proprietary formulation of tryptamine: a deuterated tryptamine. To create a deuterated drug, researchers manipulate isotopes in the compound that can change, among other things, how long drug trips last. (For a fuller explanation of what deuterated drugs can do, check out this great explainer from Truffle Report.) In the company’s press release about this development, Cybin’s CEO claims that these deuterated tryptamines could treat patients without the side effects common with some currently prescribed anxiety medications like Prozac or Xanax, which can cause weight gain, GI issues, or withdrawal symptoms. Previously, the company has reported that their deuterated formulation of psilocybin reduces negative side effects like nausea, and can shorten the duration of psychedelic effects, making sessions more manageable. This new patent would be in effect through 2041.

For anyone struggling with anxiety, this is a big step in having hope for a better future. I am truly excited about the potential of these medicines and cannot wait for it to be available to more people. We all deserve to live our best life.

A side note

Two days ago I faltered on the alcohol front. I do not want to make excuses but, we all have our triggers. For me, conflict is definitely up there. While I did not have direct conflict, the general feeling in the home was that it might lie around the corner.

It involved extended family visiting, and general disagreements about COVID, treatment, and strong opposing viewpoints. In the end I bought some wine arguing that it might help everyone just settle down some.

While it did work in that respect, I was definitely not happy to break my 57 day streak. I am however not beating myself up over it. I did not go whole hog though, which is a small blessing. It happened, it’s in the past and I am now back on day two.

Wishing you all a peaceful and clean festive season. ✌️

--

--

Schalk Neethling
Schalk Neethling

Written by Schalk Neethling

I write about mental health, addiction, sober living, living your best life through an active lifestyle and a whole food plant-based diet. Psychedelic curios :)

Responses (2)